论文部分内容阅读
我们应用硝苯吡啶治疗哮喘发作51例,并与常规治疗组46例对照,收到较好疗效,现报告如下。资料与方法97例病人均符合支气管哮喘或慢性喘息性支气管炎诊断标准,资料完整。硝苯吡啶治疗组(治疗组)51例病人,男29例,女22例,年龄15～74岁.临床类型,支气管哮喘20例,慢性喘息性支气管炎31例,病程4～32年;常规治疗组(对照组)46例,其年龄、性别、疗程、临床类型与治疗组相似。方法:对照组病人给予常规治疗,治疗组病人在常规治疗上加用硝苯吡啶。硝苯吡啶30～60mg/日,分3～4次舌下含服。病情缓解后维持
We use nifedipine treatment of asthma attack in 51 cases, and 46 cases of conventional treatment group control, received good effect, are as follows. Materials and Methods 97 patients were in line with bronchial asthma or chronic asthmatic bronchitis diagnostic criteria, the data is complete. Nifedipine treatment group (treatment group) 51 patients, 29 males and 22 females, aged 15 to 74 years.Clinical types, 20 cases of bronchial asthma, chronic asthmatic bronchitis in 31 cases, duration of 4 to 32 years; conventional The treatment group (control group) 46 cases, its age, gender, duration of treatment, clinical type and treatment group similar. Methods: The control group of patients given conventional treatment, the treatment group patients in the conventional treatment plus nifedipine. Nifedipine 30 ~ 60mg / day, sub-3 to 4 times sublingual. After remission to maintain